[Clinical polymorphism of demyelinating diseases associated with MOG-antibodies]
A S Kotov1, E S Novikova1, Yu V Metkechekova1
1Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
Abstract:
The authors present three clinical cases of demyelinating diseases associated with MOG-antibodies. In the first case of a young adult male patient, the disease first manifested with stem encephalitis and high titer of plasma MOG-antibodies. In the second case of a male adolescent, the disease proceeded as neuromyelitis optica, aquaporin-4 antibody titer was normal. In the third case, the female child the disease presented with unilateral multifocal encephalitis and focal epileptic seizures. The article emphasizes the relationship of MOG-antibody titers with the severity and prognosis of the disease.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Myocarditis II: Clinical Features and Diagnostic Tests
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
